Russian cancer vaccine: A breakthrough in Russia promises to

A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine. Russia has begun trials of a personalized mRNA cancer vaccine that detects tumor-specific mutations, creates a custom vaccine in 7 days, and is offered for free to melanoma patients—blending AI, immunotherapy, and state sponsorship. Russia has reported that its cancer vaccine "Enteromix" has completed preclinical trials—demonstrating both safety and high efficacy. Veronika Skvortsova, head of the Russian Federal Medical ... Russia's mRNA-based personalized cancer vaccine, set for free distribution in 2025, offers targeted cancer treatment with fewer side effects. Learn more about its significance.